Trials that use: ANCOVA
New to this method? Read the tutorial →
3,789 results
- Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II: primary endpoint results, effect estimate with confidence…
- Safety and Efficacy Study of Albiglutide in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Albiglutide in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00849017).
- Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG): primary endpoint results, effect estimate with confidence interval,…
- Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty: primary endpoint results, effect estimate with…
- Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01709721).
- Safety and Efficacy Study of IV Artesunate to Treat Malaria: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of IV Artesunate to Treat Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298610).
- Safety and Efficacy Study of MT-2990 in Women With Endometriosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of MT-2990 in Women With Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03840993).
- Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone: primary endpoint results, effect estimate with confidence…
- Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine: primary endpoint results, effect…
- Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss: Complete Statistical AnalysisIndependent statistical analysis of Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn: Complete Statistical AnalysisIndependent statistical analysis of Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Tolerability of Artificial Tears in Dry Eye Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Artificial Tears in Dry Eye Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932477).
- Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593606).
- Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: Complete Statistical AnalysisIndependent statistical analysis of Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: primary endpoint results, effect estimate with…
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval,…
- Safety of Optimal PEEP in NSICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety of Optimal PEEP in NSICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03862027).
- Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02927366).
- Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV): Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette’s Disorder: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a): Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…